Literature DB >> 15906325

Map-ISODATA demarcates regional response to combination rt-PA and 7E3 F(ab')2 treatment of embolic stroke in the rat.

Lian Li1, Quan Jiang, Guangliang Ding, Li Zhang, Zheng Gang Zhang, James R Ewing, Robert A Knight, Alissa Kapke, Hamid Soltanian-Zadeh, Michael Chopp.   

Abstract

PURPOSE: To investigate the ability of map-ISODATA (Iterative Self-Organizing Data Analysis Technique) to classify the different categories of ischemic damage in the lesion and to evaluate a combined (thrombolysis plus antiplatelet) treatment efficacy in an embolic stroke of rat.
MATERIALS AND METHODS: Rats subjected to embolic stroke with (N=12) and without (N=10) rt-PA and 7E3 F(ab')2 treatment (4 hours after embolization) were followed (at 2, 24, and 48 hours post-MCAO) with magnetic resonance imaging (MRI) using T1, T2, and apparent diffusion coefficient of water (ADCw). ISODATA was computed from T1, T2, and ADCw maps. The signatures characterized by the map-ISODATA were compared with histological quantitative evaluation and were employed to demarcate the specific regions in the lesion.
RESULTS: The signature described by map-ISODATA is highly correlated with the degree of tissue damage in the lesion and can distinguish the severity of ischemic tissue injury. Based upon map-ISODATA, ischemic lesion area can be divided into three specific regions, each characterized by a distinct evolution of injury and treatment response. The combined treatment significantly reduces the lesion size between 24 and 48 hours and improves the outcome 48 hours post-MCAO compared with the control group.
CONCLUSION: Map-ISODATA provides an accurate means to identify lesion area, to distinguish ischemic damage, and to detect treatment response. 7E3 F(ab')2 extends the rt-PA treatment window to at least four hours after the onset of embolic stroke of rat. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906325     DOI: 10.1002/jmri.20318

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  Transplantation of marrow stromal cells restores cerebral blood flow and reduces cerebral atrophy in rats with traumatic brain injury: in vivo MRI study.

Authors:  Lian Li; Quan Jiang; Chang Sheng Qu; Guang Liang Ding; Qing Jiang Li; Shi Yang Wang; Ji Hyun Lee; Mei Lu; Asim Mahmood; Michael Chopp
Journal:  J Neurotrauma       Date:  2011-03-24       Impact factor: 5.269

2.  Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study.

Authors:  Lian Li; Quan Jiang; Guangliang Ding; Li Zhang; Zheng Gang Zhang; Qingjiang Li; Swayamprava Panda; Mei Lu; James R Ewing; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-04       Impact factor: 6.200

3.  MRI Characterization in the Acute Phase of Experimental Subarachnoid Hemorrhage.

Authors:  Dewei Guo; D Andrew Wilkinson; B Gregory Thompson; Aditya S Pandey; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2016-11-28       Impact factor: 6.829

4.  Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke.

Authors:  Lian Li; Quan Jiang; Li Zhang; Guangliang Ding; Zheng Gang Zhang; Qingjiang Li; James R Ewing; Mei Lu; Swayamprava Panda; Karyn A Ledbetter; Polly A Whitton; Michael Chopp
Journal:  Brain Res       Date:  2006-12-26       Impact factor: 3.252

5.  A modified fuzzy C-means classification method using a multiscale diffusion filtering scheme.

Authors:  Hesheng Wang; Baowei Fei
Journal:  Med Image Anal       Date:  2008-07-05       Impact factor: 8.545

6.  MRI identification of white matter reorganization enhanced by erythropoietin treatment in a rat model of focal ischemia.

Authors:  Lian Li; Quan Jiang; Guangliang Ding; Li Zhang; Zheng Gang Zhang; Qingjiang Li; Swayamprava Panda; Alissa Kapke; Mei Lu; James R Ewing; Michael Chopp
Journal:  Stroke       Date:  2009-01-15       Impact factor: 7.914

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.